{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:33:40Z","timestamp":1786365220863,"version":"build-2736575974"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,10]]},"DOI":"10.7759\/cureus.114261","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:22:14Z","timestamp":1786364534000},"source":"Crossref","is-referenced-by-count":0,"title":["When Ultrasound and Hysterometry Disagree: Challenges in Levonorgestrel-Releasing Intrauterine System Placement"],"prefix":"10.7759","author":[{"given":"Ana","family":"Espirito Santo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gon\u00e7alo","family":"Envia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjsrh-2023-IUC","article-title":"FSRH guideline (March 2023) intrauterine contraception","volume":"49","year":"2023","unstructured":"FSRH guideline (March 2023) intrauterine contraception. BMJ Sex Reprod Health. 2023, 49.1-142. 10.1136\/bmjsrh-2023-IUC","journal-title":"BMJ Sex Reprod Health"},{"key":"ref2","article-title":"Medical Eligibility Criteria for Contraceptive Use, 5th edition","author":"World Health Organization","year":"2015","unstructured":"World Health Organization. Medical Eligibility Criteria for Contraceptive Use, 5th edition. World Health Organization, Geneva; 2015."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002400","article-title":"Practice bulletin no. 186: long-acting reversible contraception: implants and intrauterine devices","volume":"130","author":"The American College of Obstetricians and Gynecologists","year":"2017","unstructured":"The American College of Obstetricians and Gynecologists. Practice bulletin no. 186: long-acting reversible contraception: implants and intrauterine devices. Obstet Gynecol. 2017, 130:e251-69. 10.1097\/AOG.0000000000002400","journal-title":"Obstet Gynecol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2019.12.002","article-title":"Long-acting reversible contraceptive (LARCs) methods","volume":"66","author":"Bahamondes L","year":"2020","unstructured":"Bahamondes L, Fernandes A, Monteiro I, Bahamondes MV. Long-acting reversible contraceptive (LARCs) methods. Best Pract Res Clin Obstet Gynaecol. 2020, 66:28-40. 10.1016\/j.bpobgyn.2019.12.002","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fgwh.2022.1013921","article-title":"Levonorgestrel-releasing intrauterine system vs. systemic medication or blank control for women with dysmenorrhea: systematic review and meta-analysis of randomized controlled trials","volume":"3","author":"Wang J","year":"2022","unstructured":"Wang J, Deng K, Li L, Dai Y, Sun X. Levonorgestrel-releasing intrauterine system vs. systemic medication or blank control for women with dysmenorrhea: systematic review and meta-analysis of randomized controlled trials. Front Glob Womens Health. 2022, 3:1013921. 10.3389\/fgwh.2022.1013921","journal-title":"Front Glob Womens Health"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dev137","article-title":"Effect of vaginal administration of misoprostol before intrauterine contraceptive insertion following previous insertion failure: a double blind RCT","volume":"30","author":"Bahamondes MV","year":"2015","unstructured":"Bahamondes MV, Espejo-Arce X, Bahamondes L. Effect of vaginal administration of misoprostol before intrauterine contraceptive insertion following previous insertion failure: a double blind RCT. Hum Reprod. 2015, 30:1861-6. 10.1093\/humrep\/dev137","journal-title":"Hum Reprod"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e31825d9ec9","article-title":"Self-administered misoprostol or placebo before intrauterine device insertion in nulliparous women: a randomized controlled trial","volume":"120","author":"Swenson C","year":"2012","unstructured":"Swenson C, Turok DK, Ward K, Jacobson JC, Dermish A. Self-administered misoprostol or placebo before intrauterine device insertion in nulliparous women: a randomized controlled trial. Obstet Gynecol. 2012, 120:341-7. 10.1097\/AOG.0b013e31825d9ec9","journal-title":"Obstet Gynecol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007373.pub3","article-title":"Interventions for pain with intrauterine device insertion","volume":"2015","author":"Lopez LM","year":"2015","unstructured":"Lopez LM, Bernholc A, Zeng Y, Allen RH, Bartz D, O'Brien PA, Hubacher D. Interventions for pain with intrauterine device insertion. Cochrane Database Syst Rev. 2015, 2015:CD007373. 10.1002\/14651858.CD007373.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/det074","article-title":"Uterine perforation caused by intrauterine devices: clinical course and treatment","volume":"28","author":"Kaislasuo J","year":"2013","unstructured":"Kaislasuo J, Suhonen S, Gissler M, L\u00e4hteenm\u00e4ki P, Heikinheimo O. Uterine perforation caused by intrauterine devices: clinical course and treatment. Hum Reprod. 2013, 28:1546-51. 10.1093\/humrep\/det074","journal-title":"Hum Reprod"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2018.11.122","article-title":"Uterine structural abnormality and intrauterine device malposition: analysis of ultrasonographic and demographic variables of 517 patients","volume":"220","author":"Gerkowicz SA","year":"2019","unstructured":"Gerkowicz SA, Fiorentino DG, Kovacs AP, Arheart KL, Verma U. Uterine structural abnormality and intrauterine device malposition: analysis of ultrasonographic and demographic variables of 517 patients. Am J Obstet Gynecol. 2019, 220:183.e1-8. 10.1016\/j.ajog.2018.11.122","journal-title":"Am J Obstet Gynecol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015584.pub2","article-title":"Misoprostol for intrauterine device placement","volume":"9","author":"Zapata LB","year":"2025","unstructured":"Zapata LB, Snyder E, Nguyen AT, Kapp N, Ti A, Whiteman MK, Curtis KM. Misoprostol for intrauterine device placement. Cochrane Database Syst Rev. 2025, 9:CD015584. 10.1002\/14651858.CD015584.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s43043-024-00210-9","article-title":"The value of misoprostol administration before intrauterine contraceptive device insertion: a systematic review and meta-analysis","volume":"29","author":"Maged AM","year":"2024","unstructured":"Maged AM, El-Goly NA, Bassiouny N, El-Demiry N, AbdelAziz S. The value of misoprostol administration before intrauterine contraceptive device insertion: a systematic review and meta-analysis. Middle East Fertil Soc J. 2024, 29:54. 10.1186\/s43043-024-00210-9","journal-title":"Middle East Fertil Soc J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/512152-when-ultrasound-and-hysterometry-disagree-challenges-in-levonorgestrel-releasing-intrauterine-system-placement","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:22:15Z","timestamp":1786364535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/512152-when-ultrasound-and-hysterometry-disagree-challenges-in-levonorgestrel-releasing-intrauterine-system-placement"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.114261","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,10]]}}}